Joachim Baehring, MD
Professor of Neurology and of Neurosurgery; Associate Chief, Neurology; Director, Neuro-Oncology Fellowship Program, Neurology; Vice Chair, Clinical Affairs, Neurology
Research & Publications
Biography
News
Research Summary
The primary foci of Dr. Baehring's laboratory work are primary brain tumors and neurological complications of cancer.
Dr. Baehring is involved in clinical and translational research at Yale University School of Medicine. He is an investigator on numerous therapeutic trials for patients with glioblastoma, lymphoma, and other brain tumors. Other research interests include the molecular pathogenesis and development of molecular markers for primary CNS lymphoma.
Specialized Terms: Molecular markers of cancer; Nervous system lymphoma
Coauthors
Research Interests
Brain Neoplasms; Lymphoma; Medical Oncology; Neurology; Neurosurgery
Selected Publications
- Favorable Radiographic Response in a Patient With an Oligodendroglioma Treated With Azacitidine and Venetoclax for Acute Myeloid LeukemiaPerez M, Barrionuevo V, Arias C, Baehring J. Favorable Radiographic Response in a Patient With an Oligodendroglioma Treated With Azacitidine and Venetoclax for Acute Myeloid Leukemia. Cureus 2024 DOI: 10.7759/cureus.61540.
- NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.Horbinski C, Nabors L, Portnow J, Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon D, Chao S, Chheda M, Fabiano A, Forsyth P, Gigilio P, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Merrell R, Mrugala M, Nagpal S, Nedzi L, Nevel K, Nghiemphu P, Parney I, Patel T, Peters K, Puduvalli V, Rockhill J, Rusthoven C, Shonka N, Swinnen L, Weiss S, Wen P, Willmarth N, Bergman M, Darlow S. NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022. Journal Of The National Comprehensive Cancer Network 2023, 21: 12-20. PMID: 36634606, DOI: 10.6004/jnccn.2023.0002.
- Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.Nabors L, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, Butowski N, Campian J, Clark S, Fabiano A, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Horbinski C, Junck L, Kaley T, Kumthekar P, Loeffler J, Mrugala M, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli V, Robins I, Rockhill J, Rusthoven C, Shonka N, Shrieve D, Swinnen L, Weiss S, Wen P, Willmarth N, Bergman M, Darlow S. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2020, 18: 1537-1570. PMID: 33152694, DOI: 10.6004/jnccn.2020.0052.
- Whole Exome Sequencing Identifies Novel SLIT2 Mutations in Primary CNS Lymphoma (3962)Kaulen L, Erson-Omay E, Henegariu O, Karschnia P, Huttner A, Gunel M, Baehring J. Whole Exome Sequencing Identifies Novel SLIT2 Mutations in Primary CNS Lymphoma (3962). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.3962.
- Autoimmune disease-related primary CNS lymphoma: Review of literature and meta-analysis. (3990)Kaulen L, Karschnia P, Dietrich J, Baehring J. Autoimmune disease-related primary CNS lymphoma: Review of literature and meta-analysis. (3990). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.3990.
- DELAYED CEREBRAL PSEUDOANEURYSM FORMATION FROM DISSEMINATION OF ATRIAL MYXOMA (P6.108)Roque A, Baehring J, Kimbrough T, Huttner A, Traner C, Madri J, Sklar J. DELAYED CEREBRAL PSEUDOANEURYSM FORMATION FROM DISSEMINATION OF ATRIAL MYXOMA (P6.108). Neurology 2018, 90 DOI: 10.1212/wnl.90.15_supplement.p6.108.
- Leptomeningeal dissemination from low-grade neuroepithelial CNS tumors in adults: a 15-year experience (P6.159)Karschnia P, Barbiero F, Schwaiblmair M, Piepmeier J, Huttner A, Becker K, Fulbright R, Baehring J. Leptomeningeal dissemination from low-grade neuroepithelial CNS tumors in adults: a 15-year experience (P6.159). Neurology 2018, 90 DOI: 10.1212/wnl.90.15_supplement.p6.159.
- PML in the absence of HIV or immunosuppressive therapy (P2.319)Chu S, Owusu K, Brown B, Hyun E, Ranpura A, Baehring J, Miskin D, Koralnik I, Meyer A. PML in the absence of HIV or immunosuppressive therapy (P2.319). Neurology 2017, 88 DOI: 10.1212/wnl.88.16_supplement.p2.319.
- The growing teratoma syndrome after subtotal resection of an intracranial nongerminomatous germ cell tumor in an adult: case report.Bi W, Bannykh S, Baehring J. The growing teratoma syndrome after subtotal resection of an intracranial nongerminomatous germ cell tumor in an adult: case report. Neurosurgery 2005, 56: 188. PMID: 15617603.